Rhythm Pharmaceuticals, Inc. RYTM Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $62.14M-41.4% | $54.3M-39.1% | $52.08M+9.6% | $135.59M-16.1% | $106.1M+98.6% | ||
| $278.49M+33.6% | $334.65M+44.6% | $363.97M+45.1% | $155.44M-1.3% | $208.39M+41.0% | ||
| $119.43M+63.1% | $103.06M+47.0% | $95.49M+43.7% | $81.77M+32.5% | $73.24M+26.4% | ||
| $95.38M+49.2% | $86.05M+61.9% | $79.04M+83.7% | $70.82M+92.0% | $63.95M+106% | ||
| $430.09M+16.5% | $466.92M+24.8% | $494.8M+45.4% | $360.68M+0.9% | $369.29M+56.6% | ||
| $1.07M+131% | $1.1M+74.7% | $237K-70.4% | $297K-69.5% | $462K-59.8% | ||
| $5.11M-14.3% | $5.32M-13.8% | $5.53M-13.4% | $5.75M-12.9% | $5.96M-12.5% | ||
| $442.32M+14.4% | $480.2M+22.4% | $506.87M+39.4% | $372.73M-2.4% | $386.69M+49.5% | ||
| $12.3M+3.2% | $13.95M+13.1% | $13.63M+179% | $15.98M+252% | $11.91M+57.8% | ||
| —— | —— | —— | —— | $1.3M-98.8% | ||
| $10.13M— | $7.3M— | $5.56M— | —— | —— | ||
| $103.2M-7.7% | $105.94M-8.3% | $104.27M+6.8% | $129.46M+137% | $111.82M+106% | ||
| $98.34M— | $100.89M— | $103.41M— | —— | —— | ||
| $204.7M-8.5% | $210.17M-7.7% | $211.19M+0.1% | $239.15M+18.2% | $223.6M+13.5% | ||
| 120M+193,448% | 120M+196,621% | 67K+9.8% | 64K+6.7% | 62K+3.3% | ||
| -$1.41B-16.8% | -$1.35B-17.0% | -$1.3B-17.3% | -$1.25B-17.1% | -$1.2B-16.3% | ||
| $122.91M+549% | $139.07M+540% | $148.82M+1,227% | -$11.91M-130% | $18.95M-69.2% | ||
| $442.32M+14.4% | $480.2M+22.4% | $506.87M+39.4% | $372.73M-2.4% | $386.69M+49.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Rhythm Pharmaceuticals, Inc.'s total assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) holds $442.3M in total assets, up 14.4% year over year.
- How much debt does Rhythm Pharmaceuticals, Inc. have?
- Rhythm Pharmaceuticals, Inc. carries $112.3M in total debt against $122.9M of shareholders' equity, a debt-to-equity ratio of 0.91.
- How much cash does Rhythm Pharmaceuticals, Inc. have?
- Rhythm Pharmaceuticals, Inc. holds $62.1M in cash and equivalents.
- Can Rhythm Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 4.17 — current assets exceed current liabilities.
- Where does Rhythm Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
